Vascular Surgery Billing: Diagnostic vs Interventional Procedure Coding Pitfalls

Ask any experienced vascular coder where denials pile up. They'll point to the same fault line every time: the moment a diagnostic angiogram turns into an intervention. It's a split-second clinical decision that carries hours of billing consequences. Getting it wrong used to just mean a rejected claim and a resubmission. That's no longer the full picture.

A federal report released in May 2026 put a hard number on the problem. Over a hundred million dollars in Medicare payments were flagged as potentially unnecessary. CMS responded by pointing auditors straight at the codes vascular practices use every day. Diagnostic-versus-interventional coding isn't just a reimbursement question anymore. It's sitting under an audit spotlight.

Vascular surgery billing lives at the exact point where diagnostic testing ends, and treatment begins. That overlap is where the real coding traps hide: timing, medical necessity, catheter selectivity, and documentation. It either holds up under review, or it falls apart the moment someone asks a second question.

Why Diagnostic vs Interventional Coding Errors Are Under Increased Scrutiny in 2026

In May 2026, the HHS Office of Inspector General published a report on this exact issue. It examined Medicare Part B billing for peripheral vascular procedures performed in office-based labs. The findings were significant: Medicare paid roughly $548 million for these procedures in office-based labs in 2023 alone.

The OIG estimated that about 19%, or $105 million, may have gone toward services that weren't medically necessary. The report didn't accuse anyone of fraud. But it did hand CMS a list of physicians with billing patterns worth a second look, and CMS agreed to follow up. Source:  HHS-OIG

The practical fallout arrived fast. Recovery Audit Contractors expanded their review priorities to include selective catheter placement codes. Specifically, CPT 36247 (third-order or more selective arterial catheter placement) and CPT 37229 (tibial/peroneal artery revascularization with angioplasty). Both codes are commonly billed alongside the peripheral vascular procedures the OIG flagged. That means a claim built around a diagnostic-to-interventional workflow now sits at the center of two separate audit programs at once. Source:  Medical Economics

None of this means diagnostic angiography or interventional treatment should be avoided. Both are clinically necessary, often in the same session. It means the coding and documentation behind that session needs to hold up to more scrutiny than it did two years ago.

What Changed for Office-Based Labs (OBLs) Specifically

CMS has reimbursed peripheral vascular procedures at a higher rate in office-based labs since 2008. The policy was designed to shift volume out of more expensive hospital settings. That incentive structure is precisely what drew OIG's attention. Procedures performed in OBLs showed billing patterns that the report flagged for review, especially given lighter historical oversight.

For coders, this means the diagnostic-versus-interventional line gets drawn more strictly in an OBL setting than in a hospital. Auditors reviewing OBL claims look for evidence that a diagnostic angiogram wasn't simply repackaged imaging. They want proof it wasn't imaging that would always have led to the same intervention. If your practice performs vascular work in an OBL, this distinction deserves its own documentation protocol, not the same template used for hospital-based cases.

Understanding the Core Distinction: Diagnostic vs Interventional Vascular Codes

Diagnostic vascular procedures exist to evaluate a vessel and inform a treatment decision. Think catheter-based angiography, duplex ultrasound, and CT angiography. Interventional procedures angioplasty, stenting, atherectomy, embolization exist to treat what the diagnostic study found. CPT organizes these into distinct families. Diagnostic imaging generally falls under 93xxx and 75xxx codes, while therapeutic vascular interventions live in the 37xxx range.

The coding challenge isn't identifying which family a procedure belongs to. It's determining whether a diagnostic study performed during the same session as an intervention can be billed separately. That depends entirely on timing, intent, and documentation, not just on which codes were used.

When Diagnostic Angiography Can Be Billed Separately

Diagnostic angiography performed at the same session as an intervention is billable only under a "prior study" exception. Essentially, no adequate diagnostic study already existed, or the patient's condition changed enough to justify a new one. CPT recognizes only catheter-based angiograms as a qualifying prior study. Medicare, notably, treats a CT angiogram (CTA) the same way. A recent CTA on file can block separate billing for a same-session catheter angiogram, even when CPT rules alone might not require that. Source: Society for Vascular Surgery

Practical criteria to check before billing diagnostic imaging separately:

• No prior catheter-based or CT angiogram exists, or the existing study is outdated or doesn't reflect current anatomy.

• The diagnostic study changed the treatment plan in a documented, specific way.

• The physician's note distinguishes the diagnostic portion from the interventional portion in content and clinical reasoning, not just timestamps.

When Diagnostic Imaging Is Bundled Into the Intervention

If imaging is performed solely to guide catheter placement or confirm device position, it isn't separately billable. The same applies to imaging used only to verify results after treatment. This is where modifier 59 (distinct procedural service) or modifier XU (unusual non-overlapping service) come in.

But they only apply when documentation genuinely supports a separate, medically necessary diagnostic purpose. Appending a modifier just to bypass an NCCI bundling edit is exactly the pattern auditors are trained to catch.

Top Coding Pitfalls That Trigger Denials and Audits

These five errors show up in denial letters and audit findings more than any others. Most trace back to a documentation gap, not a coding mistake. Knowing them in advance is the easiest way to avoid them.

Pitfall 1: Billing Diagnostic Angiography When the Decision to Intervene Was Already Made

This is the single most common and most audited error in vascular billing. If the physician's note or prior imaging already establishes that intervention was planned, the angiogram isn't separately billable. In that case, it's considered part of the intervention itself.

A denial-prone note might read: "Patient referred for known severe SFA stenosis on prior duplex; angiogram performed, confirming stenosis, followed by angioplasty". An audit-defensible version separates the clinical reasoning instead: "Angiogram revealed a new 80% stenosis not previously characterized on duplex; findings prompted the decision to proceed with angioplasty in the same session". 

The difference is whether the record shows the study actually informed a decision, rather than just confirming one already made.

Pitfall 2: Misapplying Modifiers on Bundled Services

Modifiers 59 and XU exist to unbundle services that are normally packaged together. But they only apply when there's a genuinely distinct clinical purpose. Coders under pressure to reduce denials sometimes apply these modifiers reflexively whenever an NCCI edit blocks a claim. That's exactly the billing pattern that draws payer and RAC attention. The modifier should reflect what's documented in the chart, not what's needed to get the claim to pass.

Pitfall 3: Incorrect Catheter Selectivity Coding

Catheter placement codes depend on how far the catheter travels from the access site. Categories include non-selective, first-order, second-order, and third-order or beyond. Only the highest level of selectivity reached per vascular family is reported. Lower-level placements along the way are bundled into that code, not billed separately. 

Confusion here is common when a catheter is repositioned across multiple vascular families in one session. This is also one of the specific areas RAC auditors are now reviewing under CPT 36247.

Pitfall 4: Territory-Based Billing Errors

Lower extremity interventions are billed per vascular territory, not per lesion treated. If a surgeon performs atherectomy and angioplasty in the same femoral-popliteal territory, that's one code. CPT 37227, for example, already includes angioplasty when performed alongside stent and atherectomy in the same vessel. Billing each intervention separately because multiple lesions were treated is a common overbilling mistake. NCCI edits are specifically designed to catch it.

Pitfall 5: Insufficient Medical Necessity Documentation for PAD and CVI

Peripheral artery disease and chronic venous insufficiency claims require more than a diagnosis code. ICD-10 codes for PAD (I70.2x–I70.7x) need laterality specified clearly. The note also needs to distinguish claudication from rest pain and document any ulceration or gangrene.

The OIG report specifically flagged cases where conservative treatment wasn't clearly tried first. Documentation should show, explicitly, what conservative measures were attempted, for how long, and why they failed.

If you'd like a second set of eyes on your current diagnostic-versus-interventional coding practices, get in touch with our team for a free review.

A Documentation Framework for Audit-Defensible Coding

Rather than treating documentation as a formality, build the note around three questions. These are the questions an auditor will actually ask when reviewing the chart.

1. Did the diagnostic study change the plan, or just confirm it? State the clinical question the study was meant to answer, and what it revealed that wasn't already known.

2. Was conservative treatment tried, and did it fail? Specify the treatment, the duration, and the clinical outcome that justified moving to intervention.

3. Is the catheter selectivity and vessel territory clearly stated? Name the vessel, the territory, and the highest selectivity level reached. Vague language like "advanced into the leg" invites a downcode.

Here's a simple before-and-after example. A claim for atherectomy with a same-session diagnostic angiogram was initially denied. The note only stated "diagnostic angiogram performed before atherectomy," with no further detail. 

On appeal, the practice resubmitted with an addendum specifying new findings. The angiogram had identified a previously undocumented 90% occlusion in the tibial artery, distinct from the known SFA disease. That finding directly changed the treatment plan to include an additional territory. The claim was paid on appeal not because the coding changed, but because the documentation finally supported it.

2026 CPT Code Changes Affecting Vascular Diagnostic vs Interventional Billing

The 2026 CPT code set introduced several updates relevant to this topic. These include new and revised codes, plus the bundling of thoracic endograft repair codes that previously required separate reporting.

The American College of Radiology has also released an early look at anticipated 2027 changes. These affect interventional and diagnostic imaging codes, and vascular practices should start reviewing them now. Code bundling tends to tighten further with each update, rather than loosen. Coders should treat CPT updates as a required annual review, not a one-time read. A code that was separately billable last year may be bundled this year.

Best Practices to Reduce Denials and Audit Risk

• Build a pre-bill audit step specifically for same-session diagnostic-plus-interventional claims.

• Train coders to flag notes where diagnostic findings and treatment decisions aren't clearly sequenced.

• Use EHR documentation prompts requiring physicians to state whether a prior study existed.

• Review OBL claims against a stricter documentation standard than hospital-based claims.

• Re-audit historical claims for CPT 36247 and 37229, given current RAC priorities.

• Revisit your territory-based billing logic annually against the current NCCI edit set.

Can a vascular surgeon bill for both a diagnostic angiogram and an intervention in the same session?

Yes, but only if the diagnostic angiogram meets the "prior study" exception. This means no adequate prior study existed, or new findings changed the treatment plan. If the angiogram simply confirmed a decision already made, it's bundled into the intervention.

What modifier is used for diagnostic imaging billed alongside an interventional vascular procedure?

Modifier 59 or modifier XU, depending on payer preference. Either applies only when documentation clearly supports a distinct diagnostic purpose. Using them without that support is a common audit trigger.

Does Medicare treat a CT angiogram the same as a catheter-based angiogram as a "prior study"?

Yes. CPT technically recognizes only catheter-based angiograms as a prior study. Medicare, however, considers a CTA a prior diagnostic study as well. This can affect whether a same-session catheter angiogram is separately billable.

What triggered the 2026 OIG review of vascular procedure billing?

A May 2026 HHS-OIG report examined Medicare Part B payments for peripheral vascular procedures in office-based labs. It found that roughly 19% of 2023 payments, about $105 million, may have been medically unnecessary. CMS agreed to increase monitoring and follow up on flagged billing patterns.